JHC Systems Limited Revenue and Competitors

London, UK

Location

N/A

Total Funding

Finance

Industry

Estimated Revenue & Valuation

  • JHC Systems Limited's estimated annual revenue is currently $275.8M per year.(i)
  • JHC Systems Limited's estimated revenue per employee is $294,000

Employee Data

  • JHC Systems Limited has 938 Employees.(i)
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$55.7M241-24%N/AN/A
#2
$12.5M66-3%N/AN/A
#3
$3.4M230%N/AN/A
#4
$16.2M7728%N/AN/A
#5
$48M2082%N/AN/A
#6
$85.1M32419%N/AN/A
#7
$88.2M33640%N/AN/A
#8
$411M139817%N/AN/A
#9
$105.3M40155%N/AN/A
#10
$105.9M3975%$878.2MN/A
Add Company

What Is JHC Systems Limited?

keywords:N/A

N/A

Total Funding

938

Number of Employees

$275.8M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

JHC Systems Limited News

2022-04-06 - MCT4 Promotes Hepatocellular Carcinoma Progression | JHC

... China), the blots were visualized by ChemiDoc XRS+ system (Bio-rad ... LTD. (Shanghai, China). Stable HCCLM3 cells were established by...

2022-03-30 - Outcome in patients with hepatocellular carcinoma | JHC

... up by telephone or medical record system for overall survival (OS). ... the radiomics platform (Huiying Medical Technology Co., Ltd).

2022-03-22 - Systemic therapy for hepatocellular carcinoma: outlook | JHC

The management of HCC is mainly based on a staging system for liver cancer with ... limited efficacy only in vivo or in vitro HCC models.

2019-07-19 - Global fintech company FNZ acquires leading wealth management software firm JHC

The financial technology company FNZ announced that it acquired JHC Systems Ltd (JHC), UK-based software provider to the wealth management industry. FNZ is a global fintech firm that partners with banks, insurers, and asset managers and is responsible for more than £380 billion in assets under ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$288.9M9389%N/A
#2
$289.2M93980%N/A
#3
$35M94064%N/A
#4
$158.3M9427%N/A
#5
$320.8M9436%N/A